Literature DB >> 30454745

Nephrogenic Diabetes Insipidus.

Catherine Kavanagh1, Natalie S Uy2.   

Abstract

Nephrogenic diabetes insipidus (NDI) results from the inability of the late distal tubules and collecting ducts to respond to vasopressin. The lack of ability to concentrate urine results in polyuria and polydipsia. Primary and acquired forms of NDI exist in children. Congenital NDI is a result of mutation in AVPR2 or AQP2 genes. Secondary NDI is associated with electrolyte abnormalities, obstructive uropathy, or certain medications. Management of NDI can be difficult with only symptomatic treatment available, using low-solute diet, diuretics, and prostaglandin inhibitors.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Aquaporin; Nephrogenic diabetes insipidus; Polydipsia; Polyuria; Vasopressin

Mesh:

Substances:

Year:  2019        PMID: 30454745     DOI: 10.1016/j.pcl.2018.09.006

Source DB:  PubMed          Journal:  Pediatr Clin North Am        ISSN: 0031-3955            Impact factor:   3.278


  11 in total

1.  Identification of a Novel Arginine Vasopressin Receptor 2 Mutation (p.V183M) in a Chinese Family with Nephrogenic Diabetes Insipidus.

Authors:  Ji-Shi Liu; Hao Huang; Jie-Yuan Jin; Ran Du; Chen-Yu Wang; Liang-Liang Fan
Journal:  Mol Syndromol       Date:  2020-03-28

2.  Nephrogenic diabetes insipidus with new onset diabetic ketoacidosis in a child - challenges in fluid and electrolyte management.

Authors:  Yu-Shan Tseng; Nicole Swaney; Katherine Cashen; Amrish Jain; Nina Ma; Andrew Prout
Journal:  Pediatr Nephrol       Date:  2022-03-14       Impact factor: 3.651

3.  Triamterene in lithium-induced nephrogenic diabetes insipidus: a case report.

Authors:  Megumi Inoue; Kentaro Nakai; Koji Mitsuiki
Journal:  CEN Case Rep       Date:  2020-08-09

4.  A NOVEL INTRAGENIC DELETION RELATED TO THE ARGININE VASOPRESSIN V2 RECEPTOR CAUSES NEPHROGENIC DIABETES INSIPIDUS.

Authors:  L Chen; T Gu; L Z Yang
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

5.  Sweet and Salty: Diabetic Ketoacidosis in a Patient With Nephrogenic Diabetes Insipidus.

Authors:  Hong A De Sa; Sunhee Chung; Paul M Shaniuk
Journal:  Cureus       Date:  2021-01-13

6.  Oral disintegrating desmopressin tablet is effective for partial congenital nephrogenic diabetes insipidus with AVPR2 mutation: a case report.

Authors:  Kento Ikegawa; Rumi Hachiya; Kazuhisa Akiba; Yukihiro Hasegawa
Journal:  Clin Pediatr Endocrinol       Date:  2022-02-18

Review 7.  Grading Central Diabetes Insipidus Induced by Immune Checkpoint Inhibitors: A Challenging Task.

Authors:  Agnese Barnabei; Lidia Strigari; Andrea Corsello; Rosa Maria Paragliola; Giovanni Maria Iannantuono; Roberto Salvatori; Salvatore Maria Corsello; Francesco Torino
Journal:  Front Endocrinol (Lausanne)       Date:  2022-03-21       Impact factor: 5.555

8.  Valine-279 Deletion-Mutation on Arginine Vasopressin Receptor 2 Causes Obstruction in G-Protein Binding Site: A Clinical Nephrogenic Diabetes Insipidus Case and Its Sub-Molecular Pathogenic Analysis.

Authors:  Ming-Chun Chen; Yu-Chao Hsiao; Chun-Chun Chang; Sheng-Feng Pan; Chih-Wen Peng; Ya-Tzu Li; Cheng-Der Liu; Je-Wen Liou; Hao-Jen Hsu
Journal:  Biomedicines       Date:  2021-03-15

9.  Clinical, Genetic and Functional Characterization of a Novel AVPR2 Missense Mutation in a Woman with X-Linked Recessive Nephrogenic Diabetes Insipidus.

Authors:  Senthil Selvaraj; Dírcea Rodrigues; Navaneethakrishnan Krishnamoorthy; Khalid A Fakhro; Luís R Saraiva; Manuel C Lemos
Journal:  J Pers Med       Date:  2022-01-17

10.  Effects of a Chinese herbal extract on the intestinal tract and aquaporin in Adriamycin-induced nephropathy.

Authors:  Weizhong Ma; Xing Liang; Zhuowei Su
Journal:  Bioengineered       Date:  2022-02       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.